HIMS
Hims & Hers Health, Inc.
NYSE · Healthcare · Medical - Equipment & Services · US
$28.15
+0.29%Year over year
Reported trailing growth
- Revenue
- +28.0%
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- -24.8%
- Operating cash flow
- +2.0%
Forward estimates
Based on analyst estimates
- Revenue
- +47.7%
- EBITDA
- +570.7%
- EPS
- +156.9%
Three-year CAGR
- Revenue
- +64.5%
- EBITDA
- +100.9%
- EBIT
- +70.6%
- Net income
- +1.8%
- EPS
- -1.7%
- Free cash flow
- +25.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026